<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="retraction" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1540228</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2024.1540228</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Retraction: Designing of SiO<sub>2</sub> mesoporous nanoparticles loaded with mometasone furoate for potential nasal drug delivery: <italic>Ex vivo</italic> evaluation and determination of pro-inflammatory interferon and interleukin mRNA expression</article-title>
<alt-title alt-title-type="left-running-head">Frontiers Editorial Office</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2024.1540228">10.3389/fcell.2024.1540228</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<collab>Frontiers Editorial Office</collab>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/228891/overview"/>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Approved by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/312230/overview">Ramani Ramchandran</ext-link>, Medical College of Wisconsin, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Frontiers Editorial Office, <email>research.integrity@frontiersin.org</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>12</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>1540228</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>12</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>12</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Frontiers Editorial Office.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Frontiers Editorial Office</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="retracted-article" journal-id="Front. Cell Dev. Biol." journal-id-type="nlm-ta" xlink:href="10.3389/fcell.2022.1026477" ext-link-type="doi">A Retraction of the Original Research Article <article-title>Designing of SiO<sub>2</sub> mesoporous nanoparticles loaded with mometasone furoate for potential nasal drug delivery: <italic>Ex vivo</italic> evaluation and determination of pro-inflammatory interferon and interleukin mRNA expression</article-title> by Mehmood Y, Shahid H, Barkat K, Ibraheem M, Riaz H, Badshah SF, Chopra H, Sharma R, Nepovimova E, Kuca K, Valis M and Emran TB (2023). Front. Cell Dev. Biol. 10:1026477. doi: <object-id>10.3389/fcell.2022.1026477</object-id>
</related-article>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Molecular and Cellular Pathology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>The journal retracts the 6 January, 2023 article cited above.</p>
<p>Following publication, concerns were raised regarding the integrity of the images in this article. An investigation was conducted in accordance with Frontiers&#x2019; policies.</p>
<p>It was found that the concerns were valid and that the article does not meet the standards of editorial and scientific soundness for Frontiers in Cell and Developmental Biology; therefore, the article has been retracted.</p>
<p>The retraction was approved by the Chief Editors for Frontiers in Cell and Developmental Biology and the Chief Executive Editor of Frontiers. The authors do not approve of the retraction.</p>
</body>
</article>